The Bank of Nova Scotia on $2.3 billion Senior Medium-Term Notes Offering.

Underwriters of Steel Dynamics, Inc.’s registered offering of $600 million aggregate principal amount of 5.375% Senior Notes due 2034.

Underwriters of Bruker Corporation’s follow-on offering of 6,000,000 shares of common stock, resulting in gross proceeds of approximately $403.7 million.

Underwriters of McDonald’s Corporation’s registered offering of $500 million aggregate principal amount of 5.000% Notes due 2029 and $500 million aggregate principal amount of 5.200% Notes due 2034.

Sales agents of Mineralys Therapeutics, Inc.’s at-the-market equity offering program to offer and sell common stock having aggregate offering price of up to $100 million.

Boston Scientific Corporation on €2 billion registered offering, by wholly owned finance subsidiary, of 3.375% Senior Notes due 2029 and 3.500% Senior Notes due 2032.

Underwriters of Bell Canada’s registered offering of $700 million aggregate principal amount of 5.200% Series US-9 Notes due 2034 and $750 million aggregate principal amount of 5.550% Series US-10 Notes due 2054.

Placement agents of Mineralys Therapeutics, Inc.’s private placement of 8,339,169 shares of common stock and pre-funded warrants to purchase 549,755 shares of common stock, resulting in gross proceeds of approximately $120 million.

Underwriters of upsized follow-on offering of 2,530,000 shares of common stock of SilverBow Resources, Inc. by affiliate of Strategic Value Partners, LLC, resulting in gross proceeds of approximately $68.1 million.

Underwriters of SilverBow Resources, Inc.’s upsized follow-on offering of 4,000,000 shares of common stock, which includes 2,810,811 shares offered by SilverBow Resources and 1,189,189 shares offered by affiliate of Strategic Value Partners, LLC, resulting in gross proceeds to SilverBow Resources of approximately $104 million and to affiliate of Strategic Value Partners of approximately $44 million.

Underwriters of CSX Corporation’s registered offering of $600 million of 5.200% Notes due 2033.

Sales agent of Quantum-Si Incorporated’s at-the-market equity offering program to offer and sell Class A common stock having aggregate offering price of up to $75 million.

Underwriters of Inozyme Pharma, Inc.’s follow-on offering of 14,375,000 shares of common stock, resulting in net proceeds of approximately $64.5 million.

Banco Itaú Chile on tender offer of its common stock and ADS by affiliate of Itaú Unibanco Holding S.A.

Underwriters of The Interpublic Group of Companies, Inc.’s $300 million offering of Senior Notes.

Underwriters of Bell Canada’s registered offering of $850 million aggregate principal amount of 5.100% Series US-8 Notes due 2033.

Initial purchasers of Rule 144A/Regulation S offering by Dana Financing Luxembourg S.à r.l. of €425 million aggregate principal amount of 8.500% Senior Notes due 2031.

Underwriters of Mineralys Therapeutics, Inc.’s upsized initial public offering of 13,800,000 shares of common stock, resulting in gross proceeds of $220.8 million.

Underwriters of Paragon 28, Inc.’s follow-on offering of 6,500,000 shares of common stock, 3,750,000 shares of which are primary and 2,750,000 shares of which are secondary, resulting in gross proceeds to Paragon 28 of approximately $59.3 million and to selling shareholders of approximately $44.1 million.